期刊文献+

ERK5在大鼠脑梗死和脑出血转化中的激活表达 被引量:3

ACTIVATION OF ERK5 IN RATS WITH CEREBRAL INFARCTION OR HEMORRHAGIC TRANSFORMATION
下载PDF
导出
摘要 目的观察持续性脑缺血及脑出血转化时大鼠脑组织中细胞外信号调节激酶5(ERK5)的激活表达情况。方法 Sprague-Dawley大鼠120只,随机分为持续性缺血组、脑出血性转化组、假手术组,各40例。线栓法建立大鼠大脑中动脉栓塞模型。出血性转化组分别在大脑中动脉栓塞4、8、16、24h后拔除栓线,再灌注24h;持续性缺血组在4、8、16、24h后不拔除栓线继续栓塞24h。假手术组手术过程和时间与出血性转化组相同,但不栓塞大脑中动脉。术后2h应用BERDERSON评分法评价各组大鼠神经功能评分,采用TTC染色法观察各组大鼠脑梗死及出血情况;Western blotting检测各组大鼠磷酸化ERK5(p-ERK5)及ERK5的蛋白激活表达水平。结果持续性缺血组和脑出血性转化组大鼠均表现出不同程度的神经功能障碍。TTC染色显示,脑出血性转化组8、16、24h时在脑梗死范围内出现了不同程度的出血转化。Western blotting结果显示,持续性缺血组和脑出血性转化组各时间点p-ERK5蛋白表达量增高,与假手术组相比差异有统计学意义(F=37.02~91.85,q=4.58~18.66,P<0.05)。脑出血性转化组8、16、24h的p-ERK5蛋白表达量与4h比较、8、24h与16h比较差异均有显著意义(F=39.47,q=5.90~15.24,P<0.05)。持续性缺血组8、16、24h的p-ERK5表达量较4h显著升高,差异有显著意义(F=7.81,q=4.59~6.46,P<0.05)。3组组内不同时间点以及3组间ERK5蛋白表达差异无统计学意义(P>0.05)。结论大鼠脑缺血及脑出血转化可以诱导ERK5的激活,参与脑缺血与出血转化过程并发挥重要作用。 Objective To investigate the activation of extracellular signal-regulated kinase 5(ERK5)in rats with cerebral infarction or hemorrhagic transformation(HT). Methods A total of 120 healthy male adult Sprague-Dawley rats were equally and randomly divided into three groups:permanent ischemia group,HT group,and sham-operation group.A model of middle cerebral artery occlusion in rats was established by suture method.In the HT group,the suture was removed at 4,8,16,and 24 hafter occlusion,followed by reperfusion for 24 h;in the permanent ischemia group,the suture was not removed at 4,8,16,and 24 hafter occlusion,followed by occlusion for 24 h.The sham-operation group underwent the same procedures as the HT group except occlusion of the middle cerebral artery.The BEDERSON score was used to evaluate the neurological function at 2 h after surgery.TTC staining was used to evaluate cerebral infarction and hemorrhage.The expression of ERK5 and phosphorylated ERK5(p-ERK5)were measured by Western blot. Results Rats in the permanent ischemia group and the HT group showed neurological deficit to varying degrees.TTC staining revealed that varying degrees of HT(within the extent of cerebral infarction)was pre-sent at 8,16,and 24 hin the HT group.Western blot results showed that the expression of p-ERK5 in the permanent ischemia group and the HT group increased and were significantly higher than that in the sham-operation group(F=37.02-91.85,q=4.58-18.66,P〈0.05).In the HT group,there were significant differences in the expression of p-ERK5 at 8,16,and 24 hvs at 4 hand at 8 and 24 hvs at 16 h(F=39.47,q=5.90-15.24,P〈0.05).The expression of p-ERK5 in the permanent ischemia group significantly increased at 8,16,and 24 hvs at 4 h(F=7.81,q=4.59-6.46,P〈0.05).There were no significant differences in the expression of ERK5 at different time points in each group and between the three groups at each time point(P 0.05).Conclusion The activation of ERK5 can be induced by cerebral ischemia and HT in rats,so that ERK5 is involved in cerebral ischemia and HT and plays an important role.
作者 聂葵葵 脱淼 梁东新 宋玉强 NIE Kuikui;TUO Miao;LIANG Dongzin;SONG Yuqiang(Neurology Department, The Affiliated Hospital of Qingdao University, Qing dao 266071, China)
出处 《青岛大学学报(医学版)》 CAS 2018年第3期354-358,共5页 Journal of Qingdao University(Medical Sciences)
基金 山东省自然科学基金项目(ZR2009CM136)
关键词 脑缺血 再灌注 出血性转化 丝裂原活化蛋白激酶7 大鼠 brainiscbemia reperfusion injury bemorrbagic transformation mitogen activated protein kinase 7 rat
  • 相关文献

参考文献13

二级参考文献105

  • 1许宏伟,杨期东,刘晓英,肖波,唐北沙,赵真.MMP-2/9与脑出血后脑水肿的关系探讨[J].中风与神经疾病杂志,2004,21(4):295-297. 被引量:38
  • 2李国忠,尹燕红,王德生.出血性转化的研究进展[J].国外医学(脑血管疾病分册),2004,12(12):907-910. 被引量:15
  • 3马仁强,陈健文,庞建新,蓝秀键,邱灿华.赤芍总苷对沙土鼠全脑缺血再灌注损伤的保护作用[J].第一军医大学学报,2005,25(4):471-473. 被引量:11
  • 4Wei-Dong Wang,Li-Jian Liang,Xiong-Qing Huang,Xiao-Yu Yin.Low central venous pressure reduces blood loss in hepatectomy[J].World Journal of Gastroenterology,2006,12(6):935-939. 被引量:62
  • 5Hui-Hua Yiao.Perioperative management of primary liver cancer[J].World Journal of Gastroenterology,2007,13(13):1970-1974. 被引量:1
  • 6Adeyinka, A., Nui, Y., Cherlet, T., Snell, L., Watson, P.H., Murphy, L.C., 2002. Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. Clin. Cancer Res., 8(6): 1747-1753.
  • 7Bermudez, O., Pages, G., Gimond, C., 2010. The dual- specificity MAP kinase phosphatases: critical roles in development and cancer. Am. J. Physiol. Cell Physiol., 299(2):C189-C202. [doi:10.1152/ajpcoll.00347.2009].
  • 8Blackball, F.H., Pintilie, M., Michael, M., Leighl, N., Feld, R., Tsao, M.S., Shepherd, F.A., 2003. Expression and prog- nostic significance of kit, protein kinase B, and mitogen- activated protein kinase in patients with small cell lung cancer. Clin. Cancer Res., 9(6):2241-2247.
  • 9Bogoyevitch, M.A., 2006. The isoform-specific functions of the c-Jun N-terminal kinases (JNKs): differences revealed by gene targeting. Bioessays, 28(9):923-934. [doi:10. 1002/bies.20458].
  • 10Bogoyevitch, M.A., Arthur, P.G., 2008. Irthibitors of c-Jun N-terminal kinases: JuNK no more? Biochim. Biophys. Acta, 1784(1):76-93. [doi: 10.1016/j.bbapap.2007.09.013].

共引文献100

同被引文献49

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部